SCHEMBL23473652

SCHEMBL23473652

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)sc3ccc(-c5ccc6nc(-c7ccccc7)sc6c5)cc34)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.51
▸ SMN1; SMN2 Q16637 3/20 0.51
▸ NFKB1 P19838 2/20 0.51
▸ NFKB2 Q00653 2/20 0.51
▸ RELA Q04206 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ APP P05067 12/20 0.50
▸ MAPT P10636 6/20 0.50
▸ GAA P10253 5/20 0.50
▸ GLA P06280 4/20 0.50
▸ ALDH1A1 P00352 3/20 0.50
▸ HPGD P15428 3/20 0.50
▸ PKM P14618 2/20 0.50
▸ MEN1 O00255 1/20 0.50
▸ KMT2A Q03164 1/20 0.50
▸ RAB9A P51151 5/20 0.46
▸ NPC1 O15118 4/20 0.46
▸ POLB P06746 2/20 0.45
▸ PAX8 Q06710 2/20 0.45
▸ MITF O75030 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23473800 1.00 KDM4E (0.51) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL23473579 0.93 RAB9A (0.46) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL23473669 0.93 RAB9A (0.46) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL25548567 0.88 KDM4E (0.39) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL25459745 0.87 KDM4E (0.53) KDM4ESMN1; SMN2NFKB1NFKB2RELA
SCHEMBL24216406 0.87 PIM3 (0.45) KDM4ESMN1; SMN2LMNAMAPTGLA
SCHEMBL22240589 0.87 PIM3 (0.45) KDM4ESMN1; SMN2LMNAMAPTGLA
SCHEMBL22329716 0.87 PIM3 (0.45) KDM4ESMN1; SMN2LMNAMAPTGLA
SCHEMBL24216369 0.87 PIM3 (0.45) KDM4ESMN1; SMN2LMNAMAPTGLA
SCHEMBL24216423 0.87 PIM3 (0.45) KDM4ESMN1; SMN2LMNAMAPTGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-08-15 — — US disclosed
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. 2023-08-15 — — US disclosed
US-20210175433-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2021-06-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725138-B2 Organic electroluminescent compound and organic electroluminescent device comprising the same OR10J3, ICOSLG, TRPM4 KDM4E 1072/4885SMN1; SMN2 2381/4885NFKB1 2883/4885
US-20210175433-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, ICOSLG, TRPM4 KDM4E 1072/4885SMN1; SMN2 2381/4885NFKB1 2883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback